Immix Biopharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€18.62M +40.1% N/A -€11.56M +18.5% N/A
    €0.00 -100.0% -€13.29M +87.4% N/A -€9.75M +52.8% N/A
    -€77.12M -∞% -€7.09M -66.2% 9.2% +0.092 pp -€6.38M +366.4% 8.3% +0.083 pp
    €0.00 +NaN% -€21.01M +2,024.3% N/A -€1.37M +292.5% N/A
    €0.00 +NaN% -€988.94K +18.0% N/A -€348.67K -48.3% N/A
    €0.00 -€838.12K N/A -€674.36K N/A

    Notifications